Status:
COMPLETED
The Experiences of Patients Living With Malignant Pleural Effusions
Lead Sponsor:
Gloucestershire Hospitals NHS Foundation Trust
Conditions:
Malignant Pleural Effusion
Eligibility:
All Genders
18+ years
Brief Summary
Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.
Eligibility Criteria
Inclusion
- Adults diagnosed with a malignant pleural effusion
- Has undergone either talc pleurodesis or IPC
- Have signed a consent form prior to entering the study
- Life expectancy \> 6 weeks based on LENT guidelines (Low/Moderate risk group) - The LENT score calculation assigns 0 (\<1500 IU/L) or 1 (\>1500 IU/L) for pleural fluid LDH level; 0 to 3 points for matching ECOG performance scores (3 and 4 are combined); 0 (\<9) or 1 (\>9) for neutrophil-to-lymphocyte ratio; and 0 (lowest risk), 1 (moderate risk), or 3 (highest risk) for tumor type.
Exclusion
- Any patient who is unable to understand sufficient English to take part in the semi-structured interviews
- Weakness or fatigue sufficient so that the patient is unable to take part in the interviews
Key Trial Info
Start Date :
June 2 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03235999
Start Date
June 2 2016
End Date
January 14 2019
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gloucestershire Hospitals NHS Foundation Trust
Cheltenham, Gloucestershire, United Kingdom, GL53 7AN